Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corpeleijn

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
European Journal of Clinical Investigation|May 10, 2012
Parental history of type 2 diabetes and cardiometabolic biomarkers in offspringAli Abbasi, Eva Corpeleijn, Yvonne T van der Schouw, et al.
American Journal of Nephrology|June 3, 2026
Beyond the Amount: The Selectivity of Proteinuria and Risk of Graft Failure in Kidney Transplant RecipientsFiras F Alkaff, Wendy Dam, Jenny E Kootstra-Ros, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 5, 2011
Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipientsDorien M Zelle, Eva Corpeleijn, Ronald P Stolk, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2013
[Validity of risk scores to predict type 2 diabetes in the Dutch population]Joline W J Beulens, Ali Abbasi, Linda M Peelen, et al.
Nutrients|January 10, 2026
Vitamin C and Benzoic Acid Intake in Patients with Kidney Disease: Is There Risk of Benzene Exposure?Manuela Yepes-Calderón, Caecilia S E Doorenbos, Eva Corpeleijn, et al.
Free Radical Biology & Medicine|March 5, 2025
Effect of lifestyle intervention on systemic oxidative stress in kidney transplant recipients: A post-hoc analysis of the Active Care after Transplantation (ACT) randomized controlled trialArno R Bourgonje, Tim J Knobbe, Daan Kremer, et al.
Diabetologia|June 5, 2014
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyAli Abbasi, Eva Corpeleijn, Ron T Gansevoort, et al.
Nutrients|May 27, 2026
Vitamin B<sub>12</sub> Supplementation: Is More Always Better?Manuela Yepes-Calderón, Caecilia S E Doorenbos, Mariken E Stegmann, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndromeAli Abbasi, Eva Corpeleijn, Douwe Postmus, et al.
Clinical Chemistry|January 8, 2017
Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND StudyAli Abbasi, Lyanne M Kieneker, Eva Corpeleijn, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
European Journal of Clinical Investigation|May 10, 2012
Parental history of type 2 diabetes and cardiometabolic biomarkers in offspringAli Abbasi, Eva Corpeleijn, Yvonne T van der Schouw, et al.
American Journal of Nephrology|June 3, 2026
Beyond the Amount: The Selectivity of Proteinuria and Risk of Graft Failure in Kidney Transplant RecipientsFiras F Alkaff, Wendy Dam, Jenny E Kootstra-Ros, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 5, 2011
Low physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipientsDorien M Zelle, Eva Corpeleijn, Ronald P Stolk, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2013
[Validity of risk scores to predict type 2 diabetes in the Dutch population]Joline W J Beulens, Ali Abbasi, Linda M Peelen, et al.
Nutrients|January 10, 2026
Vitamin C and Benzoic Acid Intake in Patients with Kidney Disease: Is There Risk of Benzene Exposure?Manuela Yepes-Calderón, Caecilia S E Doorenbos, Eva Corpeleijn, et al.
Free Radical Biology & Medicine|March 5, 2025
Effect of lifestyle intervention on systemic oxidative stress in kidney transplant recipients: A post-hoc analysis of the Active Care after Transplantation (ACT) randomized controlled trialArno R Bourgonje, Tim J Knobbe, Daan Kremer, et al.
Diabetologia|June 5, 2014
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyAli Abbasi, Eva Corpeleijn, Ron T Gansevoort, et al.
Nutrients|May 27, 2026
Vitamin B<sub>12</sub> Supplementation: Is More Always Better?Manuela Yepes-Calderón, Caecilia S E Doorenbos, Mariken E Stegmann, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndromeAli Abbasi, Eva Corpeleijn, Douwe Postmus, et al.
Clinical Chemistry|January 8, 2017
Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND StudyAli Abbasi, Lyanne M Kieneker, Eva Corpeleijn, et al.
Pageof 17